In the year 2014, the 'cytomegalovirus community' of researchers commemorated the 60th anniversary of cytomegalovirus isolation by Margaret Gladys Smith (1896 Smith ( -1970 , former faculty member and Professor of Pathology at the Washington University in St. Louis, School of Medicine (Fig. 1 ). The year 1954 brought a number of chronicle events: the 'birth' of cytomegalovirus in Saint Louis/ Missouri, a total solar eclipse, the 'Niagara rock fall', the 'miracle of Bern,' and, last and least, a baby boy was born in the Bavarian Alps for whom the scientific achievements by Margaret Gladys Smith should become sort of destiny.
Histopathological alterations characteristic of infection by an agent now known as cytomegalovirus, namely enlarged 'cytomegalic' cells with intranuclear inclusions, were first observed by the pathologist Dr. Ribbert in sections of the kidney of a stillborn presenting with Lues-like symptoms and interstitial nephritis. The 'cradle of cytomegalovirus' is Dr. Ribbert's case report given at a meeting of the medical section of the Natural History Society of Prussian Rhineland and Westphalia, held on June 27, 1881, in Bonn, Germany [1] . After a period when cytomegalic cells were mistaken for protozoa, specifically for Gregarines, ([2] , see also [3] ), von Glahn and Pappenheimer were first to propose a viral etiology of the intranuclear inclusions associated with visceral disease [4] . In 1950, Wyatt et al. [5] coined the figurative name 'cytomegalic inclusion disease (CID)' for the clinical manifestations in newborns after congenital infection, though a (Fig. 2) .
The turn of eras from descriptive science to research into pathomechanisms and interventional strategies was only made possible by getting access to the virus, and this is the merit of Margaret Gladys Smith (Figs. 2 and 3) . In 1954, she first succeeded in isolating murine cytomegalovirus from salivary glands of mice and propagating it in cell culture of murine cells [8] , the prototype strain named after her and still in use as the 'Smith strain' (Fig. 4) . Soon thereafter, in 1955, she also succeeded in growing submaxillary salivary gland-derived human cytomegalovirus in human cell culture, but her submitted manuscript was rejected because the editors suspected she accidentally might have grown the murine virus on the human cells. She reproduced her pioneering findings with the kidney of a 1-month-old infant, who died of CID, as the clinical source of the virus, and eventually published the propagation of human cytomegalovirus in human cell culture in 1956 [9] , back-to-back with a similar report by Rowe et al. [10] .
She introduced her paper on the propagation of human cytomegalovirus [9] with the words:
It is now well recognized that there exist in man, monkeys and several rodents closely related viruses, which lie dormant in the salivary glands, but are capable of causing fatal generalized infections with visceral necrosis. A general term for these agents is salivary gland virus (SGV). Each virus or strain of the virus is probably species-specific, since all attempts to infect animals of one species with virus derived from another species have failed.
Thus, besides her outstandingly important achievement of growing cytomegaloviruses in cell culture, Margaret Gladys Smith deserves to be honored for having recognized the host species-specificity of cytomegaloviruses, a phenomenon revisited from a molecular view in this issue of MMI in the contribution by Wolfram Brune's group.
Standing in the scientific tradition of Margaret Gladys Smith, the team of authors of this special issue is proud to present current research on cytomegaloviruses, clinical research as well as primate and rodent models, starting with Stanley Plotkin's 'special guest' synopsis of trials and progress in the development of a cytomegalovirus vaccine, followed by 20 articles ranging from current clinical topics to the cell biology and immunology of cytomegaloviruses. With this, I hand over to Dr. Edward S. Mocarski, who will introduce Dr. Stanley A. Plotkin. 
